Determining the clinicopathological significance of the VI-RADS >==4 group: a retrospective study. Ikuma S, Akatsuka J, Takeda H, Endo Y, et al. BMC Urol 2024;24:63.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ikuma S, Akatsuka J, Takeda H, Endo Y, et al. Determining the clinicopathological significance of the VI-RADS >==4 group: a retrospective study. BMC Urol 2024;24:63.
PMID: 38509503